Skip to main content
. 2022 May 17;24(1):212. doi: 10.3892/ol.2022.13333

Table IV.

Multivariate analysis of DFS of patients with stage I–III CRC.

Univariate Multivariate


Variables HR 95% CI P-value HR 95%CI P-value
Gender (Male) 1.54 0.73-3.53 0.26
Age (≥71 years)a 0.83 0.41-1.70 0.60
Location (Rectum) 1.00 0.48-2.04 0.99
Differentiation (Undifferentiated) 2.17 0.64-5.57 0.19 1.58 0.46-4.21 0.43
Pathological T category (T3/T4) 2.48 1.15-5.92 0.02c 1.87 0.82-4.71 0.14
Vessel invasion (Present) 1.64 0.78-3.78 0.19 1.32 0.59-3.17 0.51
Lymph node metastasis (Present) 2.18 1.06-4.44 0.04c 1.22 0.54-2.79 0.62
MSI (MSI-L/MSS) 2.51 0.54-44.6 0.29
KRAS (Wild) 1.19 0.59-2.46 0.63
BRAF (Wild) 2.02 0.43-36.0 0.44
CD66b+ (Low) 3.12 1.41-7.88 0.004
CD8+ (Low) 3.35 1.46-9.06 0.003
CD8+CD66b+ (Low-Low)b 3.04 1.48-6.47 0.002c 2.52 1.18-5.58 0.02c
a

The median age at surgery was 71 years in this cohort;

b

The cutoff value was determined using ROC curve analysis for survival;

c

P<0.05. CRC, colorectal cancer; DFS, disease-free survival; HR, hazard ratio; CI, confidence interval.